Wall Street brokerages forecast that Trupanion Inc (NYSE:TRUP) will report $61.50 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Trupanion’s earnings, with the lowest sales estimate coming in at $61.00 million and the highest estimate coming in at $62.00 million. Trupanion posted sales of $48.36 million in the same quarter last year, which suggests a positive year over year growth rate of 27.2%. The company is expected to issue its next quarterly earnings results on Tuesday, November 7th.
According to Zacks, analysts expect that Trupanion will report full-year sales of $61.50 million for the current fiscal year, with estimates ranging from $238.20 million to $240.00 million. For the next fiscal year, analysts forecast that the firm will report sales of $291.45 million per share, with estimates ranging from $287.90 million to $295.00 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Trupanion.
Trupanion (NYSE:TRUP) last posted its quarterly earnings data on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.03) by $0.01. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The business had revenue of $58.30 million for the quarter, compared to analysts’ expectations of $57.58 million. During the same quarter in the previous year, the business posted ($0.03) earnings per share. The business’s revenue was up 27.3% compared to the same quarter last year.
A number of analysts recently issued reports on TRUP shares. Northland Securities started coverage on Trupanion in a research report on Friday, May 26th. They set an “outperform” rating and a $22.75 price objective for the company. ValuEngine raised Trupanion from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Cowen and Company reissued a “buy” rating and set a $19.00 price objective on shares of Trupanion in a research report on Friday, July 14th. Zacks Investment Research raised Trupanion from a “sell” rating to a “hold” rating in a research report on Tuesday, July 18th. Finally, TheStreet raised Trupanion from a “d” rating to a “c-” rating in a research report on Monday, July 17th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. Trupanion currently has an average rating of “Buy” and an average target price of $24.50.
Shares of Trupanion (NYSE TRUP) traded up 1.75% during mid-day trading on Friday, hitting $23.26. 464,763 shares of the stock were exchanged. The stock’s market cap is $697.71 million. Trupanion has a 12 month low of $13.71 and a 12 month high of $25.00. The company has a 50-day moving average price of $22.55 and a 200-day moving average price of $19.18.
COPYRIGHT VIOLATION WARNING: This news story was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/09/17/trupanion-inc-trup-expected-to-announce-quarterly-sales-of-61-50-million.html.
In related news, COO Ian Moffat sold 8,552 shares of the firm’s stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $23.20, for a total transaction of $198,406.40. Following the completion of the transaction, the chief operating officer now directly owns 8,552 shares in the company, valued at approximately $198,406.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Darryl Rawlings sold 3,500 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $21.13, for a total value of $73,955.00. Following the transaction, the insider now owns 1,449,505 shares of the company’s stock, valued at $30,628,040.65. The disclosure for this sale can be found here. Insiders have sold a total of 54,052 shares of company stock valued at $1,220,809 over the last 90 days.
Institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in Trupanion by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 650,459 shares of the financial services provider’s stock valued at $9,249,000 after acquiring an additional 23,419 shares during the period. Handelsinvest Investeringsforvaltning boosted its holdings in Trupanion by 598.3% during the 2nd quarter. Handelsinvest Investeringsforvaltning now owns 209,500 shares of the financial services provider’s stock valued at $4,689,000 after acquiring an additional 179,500 shares during the period. Gerber Kawasaki Wealth & Investment Management purchased a new position in Trupanion during the 2nd quarter valued at about $1,300,000. Bank of New York Mellon Corp boosted its holdings in Trupanion by 14.1% during the 1st quarter. Bank of New York Mellon Corp now owns 56,991 shares of the financial services provider’s stock valued at $811,000 after acquiring an additional 7,054 shares during the period. Finally, RMB Capital Management LLC boosted its holdings in Trupanion by 10.5% during the 1st quarter. RMB Capital Management LLC now owns 241,617 shares of the financial services provider’s stock valued at $3,436,000 after acquiring an additional 22,935 shares during the period.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.